Year : 2009 | Volume
: 20 | Issue : 5 | Page : 789--793
C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients
Nazila Bagheri, Omolbanin Taziki, Kianoosh Falaknazi
Taleghani Medical Center (Nephrology and Transplantation Ward), Shahid Beheshti Medical University, Tehran, Iran
Taleghani Medical Center (Nephrology and Transplantation Ward), Shahid Beheshti Medical University, Tehran
Overall and cardiovascular mortality are significantly higher in hemodialysis patients with elevated C-reactive protein (CRP). The aim of study was to determine whether CRP, low albumin and troponin are markers of overall and cardiovascular mortality in hemodialysis patients. 138 stable hemodialysis patients were divided into 2 groups n= 66 patients with coronary disease equivalent (known coronary or peripheral vascular disease or diabetes mellitus) and n= 72 patients without it. The two groups were then stratified by biomarkers [cardiac troponin T and Albumin and highly sensitive CRP (hs-CRP)] and followed for 30 months. The primary outcome was all causes mortality. Patients with coronary disease equivalents had 3.5 fold greater annual mortality compared to controls (24%% vs 6.9%, P value = 0.005). Elevated troponin T had a further increase in the risk for death while hs-CRP and low albumin were not associated with risk of death In conclusion, circulating cardiac troponin-T was associated with poor prognosis especially in hemodialysis patients with coronary risk factors.
|How to cite this article:|
Bagheri N, Taziki O, Falaknazi K. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.Saudi J Kidney Dis Transpl 2009;20:789-793
|How to cite this URL:|
Bagheri N, Taziki O, Falaknazi K. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients. Saudi J Kidney Dis Transpl [serial online] 2009 [cited 2020 Oct 26 ];20:789-793
Available from: https://www.sjkdt.org/text.asp?2009/20/5/789/55362
Maintenance hemodialysis (HD) patient's exhibit increased cardiovascular mortality and vascular events account for more than half of deaths in this population. 
The stratification of asymptomatic patients with end stage renal disease (ESRD) into higher and lower risk groups would be useful for identifying patients who might benefit from aggressive evaluation and treatment.
Previous studies have suggested that troponins could be a predicative tool in coronary heart disease in ESRD. , However, troponin levels in the HD patients could be influenced by factors other than ischemic damage such as retention due to lack of excretion or uremic cardiomyopathy. 
We proposed that dividing stable patients with ESRD on maintenance HD into different clinical subsets by presence or absence of known coronary disease equivalent would lead to clearer risk stratification by abnormal cardiac troponin T as well as hs-CRP and albumin.
138 hemodialysis patients from three hemodialysis centers were evaluated from June 2005 to December 2007.
Demographic and medical data were obtained from patients' interviews, chart reviews and hospital information system. Inclusion criteria included all of patients who were on maintenance HD for > 6 months.
The exclusion criteria included:
Systemic inflammation such as active autoimmune disease, infectious diseasesOngoing ischemia or any revascularization procedure during recent 8 weeks. Informed consent was obtained from all patients.The primary outcome variable was all cause mortality. Mortality data was collected by searching death records, from hospital charts, and through family phone interviews.
Diabetic patients or patients who had peripheral vascular disease were classified as patients having potential coronary artery disease. Patients with previous documented myocardial infarction or a history of surgical or percutaneous coronary revascularization, were defined as having coronary artery disease.
Peripheral vascular disease was defined as having any of the following: carotid artery stenosis of > 50%, abdominal or thoracic aortic aneurysm and peripheral arterial disease. Blood sample for hs-CRP and troponin T were measured before the beginning of mid week hemodialysis session for three consecutive months.
Serum troponin T level were measured by electrochemiluminescence immune assay and hsCRP by nephlometry (CV th percentile for reference population being 0.01 mg/L. Laboratory personnel were unaware of patient's clinical data. Following the recommendation of Center for Disease Control and Prevention and the American heart association  the 2 clinical groups (patients with coronary disease and those without) were further stratified by hs-CPR values( 3 mg/L) and C-TnT was defined as being 0.05 mg/L and > 0.05 mg/L.
Patients were divided into two groups. Group I: patient who had coronary disease. Group II: with no history of coronary artery disease or risk factors.
Cardiac troponin T and hs-CRP and mortality were compared between two groups.
Clinical variable are reported as mean ± SD and categorical variable as percentages. Fishers exact test was used to compare categorical variables, and continuous variables were evaluated using unpaired student ' s t test. P 3mg/L) in (n= 32) 23.1% patients. C-TnT was found to be elevated in (40%) (n= 56/138) of patients. C-TnT was higher in Group I compared to Group II 46/66 (69.6%) vs 10/72 (13/8%) (P value = 0.03), [Table 2].
In Group I patients with elevated C-TnT > 0.1 ng/dL had 3.5 fold greater mortality (24.2% vs 6.9%, P= 0.005).
Hs-CRP (> 3 mg/L) evaluated in group I did not add to the mortality risk. Both groups had similar high serum levels of hs-CRP (group I: n= 7 vs group II: n= 4, P= 0.24), [Table 2] but mortality was higher in patients with high hs-CRP (34% vs 9%) without considering the CAD risk factors.
There was not any significant difference between serum albumin levels in the two groups.
Serum C-TnT and hs-CRP elevated in hemodiaysis patients, posses a common clinical problem in patients with ESRD. Several studies have supported that elevation of C-TnT and hs-CRP as predictors of increased mortality. ,,,
In our study, we evaluated the clinical risks for coronary artery disease in association with the.
The findings of the present study are compatible with previous studies but are unique in several aspects.
We found that large percentage of asymptomatic patients with ESRD have elevations of C-TnT, compatible with other studies. ,, Our study also confirmed that C-TnT is independent predictor of all cause mortality in these patients further more cTnT alone had better predictive value than C-reactive protein (CRP) alone for mortality and first cardiovascular events. 
As it is shown in [Table 1], the age and duration of hemodialysis in group 1 was higher (P 
Our studies showed serum albumin and hsCRP were not significantly different in two groups although pervious studies describe that serum CRP and albumin in ESRD patients are strong predictors for cardiovascular mortality. , .This may be due to the small sample size in our patients. The most common cause of mortality in HD patients is cardiovascular diseases (CVD), while the most common cause of co-morbidity is infections  which is associated with higher CRP levels compared with cardiac death.  .
The CRP levels are highly variable and influenced by intercurrent events in dialysis patients. Use of statins may reduce the CRP levels although these agents are not shown to reduce the cardiovascular mortality in diabetic dialysis patients. 
Furthermore, higher levels of cTnT may identify patients with severe angiographic coronary disease. 
Our patients in Group I had significant cardiac disease as shown in [Table 1]; prevalence of dyslipidemia and heart failure was higher in this group.
In addition some studies have not found an association between malnutrition/inflammation and an increased risk of atherosclerosis among dialysis patients , which is compatible to some extent with our study also.
In conclusion, C-TnT per se is more helpful in risk stratifying of patients with ESRD and coronary disease equivalent. Elevated hs-CRP and low albumin level was not associated with coronary artery disease related mortality and may be a better predictor of death due to inflammation and infection in further larger studies in maintenance HD patients.
|1||Khan IA, Wattanasuwan N, Mehta NJ, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long term hemodialysis: a two years outcome analysis. J Am Coll Cardiol 2000;38: 991-8.|
|2||Chen P, Tanasejivic M. Use of serum cardiac troponin-I level in dialysis patients. Semin Dial 2000;13:58-9.|
|3||London GM. Cardiovascular disease in chronic renal failure pathophysiologic aspect. Semin Dial 2003;16:85-94.|
|4||Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.|
|5||Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponins I and T for subsequent death in end stage renal disease. Circulation 2002;106:2941-5.|
|6||Roppolo LP, Fitzgerald R, Dillow J, Ziegler T, Rice M, Maisel A. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a veteran's hospital: a pilot study. J Am Coll Cardiol 1999;34:448-54.|
|7||Zimmerman J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-58.|
|8||Yeun J, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-76.|
|9||Fehr T, Knoflach A, Ammann P, Pei P, Binswanger U. Differential use of cardiac troponin T versus I in hemodialysis patients. Clin Nephrol 2003;59:35-9.|
|10||Wang AY, Lam CW, Wang M, et al. Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients. Clin Chem 2007;53(5):882-9.|
|11||Kanwar M, Hashem M, Rosman H, et al. Usefulness of clinical evaluation, troponins, and Creactive protein in predicting mortality among stable hemodialysis patients. Am J Cardiol 2006;98:1283-7.|
|12||Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469.|
|13||Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998;54:627-63.|
|14||deFilippi C, Wasserman S, Rosanio S, Tiblier E. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353.|
|15||Akdag I, Yilmaz Y, Kahvecioglu S, et al. Clinical value of the malnutrition-inflammation atherosclerosis syndrome for long term prediction of cardiovascular mortality in patients with end stage renal disease: a 5-year prospective study. Nephron Clin Pract 2008;108(2):c99-c105.|
|16||Sit D, Kadiroglu AK, Kayabasi H, Kara IH, Yilmaz Z, Yilmaz ME. The evaluation incidence and risk factors of mortality among patients with end stage renal disease in Southeast Turkey. Ren Fail 2008;30(1):37-44.|
|17||Koch M, Haastert B, Trapp R. The prognostic value of the C-reactive protein levels in HD patients with death risk from infection. Clin Nephrol 2007;68(1):18-25|
|18||van der Sande FM, Kooman JP, Leunissen KM. The predictive value of C-reactive protein in end stage renal disease: is it clinically significant? Blood Purif 2006;24(4):335-41.|
|19||deFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing longterm hemodialysis. JAMA 2003;290(3):353-9|
|20||Beddhu S, Pappas LM, Ramkumar N, Samore MH. Malnutrition and atherosclerosis in dialysis patients. J Am Soc Nephrol 2004;15:733.|
|21||Stenvinkel P, Heimburger O, Lindholm B. Wasting, but not malnutrition, predicts cardiovascular mortality in end-stage renal disease. Nephrol Dial Transplant 2004;19:2181.|